Does United Healthcare Cover Zepbound?

TL;DR

• UnitedHealthcare may cover Zepbound, but coverage depends entirely on your specific plan. Most employer sponsored plans that include GLP-1 weight loss drug benefits will cover Zepbound with prior authorization.

• Prior authorization is always required. You will need to meet BMI criteria (30 or higher, or 27 or higher with a weight-related condition), show documentation of lifestyle modifications, and in many plans, try phentermine first.

• UHC does not require you to try Wegovy or Saxenda before getting Zepbound approved, which sets it apart from some other insurers.

Does Your Specific Plan Include Zepbound?

The short answer is: it depends on your plan. Whether Zepbound is covered comes down to whether your specific plan includes weight loss medication benefits.

Employer sponsored plans are most common path to coverage. Some employers opt to include GLP-1 weight loss drug coverage as part of their pharmacy benefits, while others exclude it entirely. If your employer's plan includes this benefit, Zepbound will typically appear on OptumRx formulary (OptumRx is UHC's pharmacy benefit manager) and be accessible with prior authorization.

Individual and marketplace plans through UHC rarely cover Zepbound for weight loss. Medicare Part D plans also do not cover Zepbound for weight loss, because Medicare currently excludes weight loss drugs from Part D coverage by federal law. However, some UHC Medicaid plans in certain states have begun adding Zepbound to their preferred drug lists. For example, UnitedHealthcare Community Plan in Massachusetts added Zepbound to its preferred formulary effective January 2025 for Senior Care Options and One Care plans.

The fastest way to check your coverage is to call member services number on back of your insurance card and ask specifically whether Zepbound (tirzepatide) is covered under your pharmacy benefits for weight management.

What Are Prior Authorization Requirements?

When UHC does cover Zepbound, prior authorization is required in every case. Your doctor will need to submit documentation to UHC before prescription can be filled. Based on UHC's official clinical pharmacy policy for weight loss medications, typical criteria include following.

You need a BMI of 30 or greater, or a BMI of 27 to 29 with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease. You also need documentation showing that you have made lifestyle modifications including dietary changes and physical activity.

Many UHC plans require step therapy, meaning you must try a lower-cost weight loss medication before Zepbound can be approved. The most common step therapy requirement is a trial of phentermine (with or without topiramate). However, UHC does not require you to try and fail Wegovy or Saxenda before approving Zepbound. This is a meaningful distinction, because some other insurers do require a semaglutide trial first.

If you meet criteria, initial authorization for Zepbound is typically issued for 6 months. Reauthorization for continued use is issued for 12 months at a time, provided you show continued benefit from medication.

UHC has also introduced automated prior authorization for select GLP-1 medications. Qualifying requests can be processed in as little as 29 seconds, though more complex cases may take up to 72 hours. This is significantly faster than traditional one to two week turnaround.

How Much Will You Pay With UHC Coverage?

If your plan covers Zepbound, your out-of-pocket cost depends on your plan's tier structure, copay or coinsurance levels, and deductible status.

On most UHC commercial plans that cover GLP-1s, Zepbound sits on a specialty tier (Tier 3 or Tier 4). This typically means a higher copay or coinsurance compared to generic medications. Depending on your plan, you might pay anywhere from $25 to $150 per month on generous employer plans, or face 25% to 50% coinsurance on plans with higher cost-sharing.

Eli Lilly offers a Zepbound Savings Card for commercially insured patients. If your UHC plan covers Zepbound, savings card can reduce your copay to as low as $25 per month. This card does not apply to government-funded plans like Medicare, Medicaid, or Tricare.

Without any insurance coverage, Zepbound's retail price averages around $1,500 per month. Eli Lilly's self-pay option through LillyDirect starts at $299 per month for 2.5 mg dose in vial form. If your plan does not cover Zepbound and you are exploring broader landscape, this overview of what insurance covers Zepbound breaks down which major carriers are most likely to approve it.

What If Your UHC Plan Denies Coverage?

If your prior authorization is denied, you have options. The first step is to ask your provider to submit a formulary exception request with additional clinical documentation. This might include detailed records of failed prior weight loss attempts, lab results showing weight related conditions, and a letter from your doctor explaining why Zepbound is medically necessary.

If exception is denied, you can file a formal appeal through UHC's internal appeals process. UHC is required to review your appeal and provide a written decision. If internal appeal is also denied, you can request an external review through your state's insurance department, where an independent third party will evaluate your case.

Appeals have a reasonable success rate when supported by thorough documentation. Keep records of everything: your BMI history, prior medications tried and why they were stopped, lab work showing comorbidities, and any notes from your provider supporting medical necessity of Zepbound specifically.

Can You Get Mounjaro Instead?

Zepbound and Mounjaro are same active ingredient, tirzepatide, but they are approved for different uses. Mounjaro is FDA-approved for type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea.

If you have both obesity and type 2 diabetes, your provider may be able to prescribe Mounjaro for diabetes management, which may be covered under a different part of your UHC formulary even when Zepbound is not. The weight loss would be a secondary benefit of treating your diabetes. If cost is a concern and you have a diabetes diagnosis, exploring Mounjaro coverage alongside tools like Mounjaro savings card could be a practical alternative.

If you do not have type 2 diabetes, Mounjaro is unlikely to be covered off-label for weight loss through UHC.

Conclusion

UnitedHealthcare can cover Zepbound, but it depends on your plan type and whether your employer includes GLP-1 weight loss drug benefits. Prior authorization is always required, with BMI criteria, lifestyle documentation, and often a phentermine trial. The good news is that UHC does not require a semaglutide trial first, and automated prior authorization can speed up approvals dramatically. Check your specific plan, work with your provider on documentation, and know that appeals are a viable path if your first request is denied.